Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Examination of clinical and laboratory measures of static and dynamic balance in breast cancer survivors.

Evans ES, Ketcham CJ, Hibberd JC, Cullen ME, Basiliere JG, Murphy DL.

Physiother Theory Pract. 2019 Nov 19:1-11. doi: 10.1080/09593985.2019.1692391. [Epub ahead of print]

PMID:
31742463
2.

Clenbuterol induces cardiac myocyte hypertrophy via paracrine signalling and fibroblast-derived IGF-1.

Bhavsar PK, Brand NJ, Felkin LE, Luther PK, Cullen ME, Yacoub MH, Barton PJ.

J Cardiovasc Transl Res. 2010 Dec;3(6):688-95. doi: 10.1007/s12265-010-9199-1. Epub 2010 Jun 25.

PMID:
20577844
3.

Mapping transcriptional start sites and in silico DNA footprinting.

Cullen ME, Barton PJ.

Methods Mol Biol. 2007;366:203-16.

PMID:
17568126
4.

Molecular signature of recovery following combination left ventricular assist device (LVAD) support and pharmacologic therapy.

Hall JL, Birks EJ, Grindle S, Cullen ME, Barton PJ, Rider JE, Lee S, Harwalker S, Mariash A, Adhikari N, Charles NJ, Felkin LE, Polster S, George RS, Miller LW, Yacoub MH.

Eur Heart J. 2007 Mar;28(5):613-27. Epub 2006 Nov 28.

PMID:
17132651
5.

Myocardial expression of the arginine:glycine amidinotransferase gene is elevated in heart failure and normalized after recovery: potential implications for local creatine synthesis.

Cullen ME, Yuen AH, Felkin LE, Smolenski RT, Hall JL, Grindle S, Miller LW, Birks EJ, Yacoub MH, Barton PJ.

Circulation. 2006 Jul 4;114(1 Suppl):I16-20.

PMID:
16820567
6.

Myocardial insulin-like growth factor-I gene expression during recovery from heart failure after combined left ventricular assist device and clenbuterol therapy.

Barton PJ, Felkin LE, Birks EJ, Cullen ME, Banner NR, Grindle S, Hall JL, Miller LW, Yacoub MH.

Circulation. 2005 Aug 30;112(9 Suppl):I46-50.

PMID:
16159864
7.

The slow skeletal muscle troponin T gene is expressed in developing and diseased human heart.

Barton PJ, Felkin LE, Koban MU, Cullen ME, Brand NJ, Dhoot GK.

Mol Cell Biochem. 2004 Aug;263(1-2):91-7.

PMID:
15524170
8.

Structure and regulation of human troponin genes.

Cullen ME, Dellow KA, Barton PJ.

Mol Cell Biochem. 2004 Aug;263(1-2):81-90. Review.

PMID:
15524169
9.

The slow skeletal muscle troponin T gene is expressed in developing and diseased human heart.

Barton PJ, Felkin LE, Koban MU, Cullen ME, Brand NJ, Dhoot GK.

Mol Cell Biochem. 2004 Aug;263(1):91-7. doi: 10.1023/B:MCBI.0000041851.53074.72.

PMID:
27520668
10.

Structure and regulation of human troponin genes.

Cullen ME, Dellow KA, Barton PJ.

Mol Cell Biochem. 2004 Aug;263(1):81-90. doi: 10.1023/B:MCBI.0000041850.37415.b8.

PMID:
27520667
11.

Increased expression of extracellular matrix regulators TIMP1 and MMP1 in deteriorating heart failure.

Barton PJ, Birks EJ, Felkin LE, Cullen ME, Koban MU, Yacoub MH.

J Heart Lung Transplant. 2003 Jul;22(7):738-44.

PMID:
12873541
12.

Genes encoding troponin I and troponin T are organized as three paralogous pairs in the mouse genome.

Barton PJ, Mullen AJ, Cullen ME, Dhoot GK, Simon-Chazottes D, Guénet JL.

Mamm Genome. 2000 Oct;11(10):926-9. No abstract available.

PMID:
11003710
13.

Close physical linkage of human troponin genes: organization, sequence, and expression of the locus encoding cardiac troponin I and slow skeletal troponin T.

Barton PJ, Cullen ME, Townsend PJ, Brand NJ, Mullen AJ, Norman DA, Bhavsar PK, Yacoub MH.

Genomics. 1999 Apr 1;57(1):102-9.

PMID:
10191089
14.

Mentoring mission leaders of the future. Program prepares laity for ministry leadership.

Cullen ME, Richardt S, Hume R.

Health Prog. 1997 Sep-Oct;78(5):36-8, 43.

PMID:
10173540
15.

GATA-1 DNA binding activity is down-regulated in late S phase in erythroid cells.

Cullen ME, Patient RK.

J Biol Chem. 1997 Jan 24;272(4):2464-9.

16.

Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.

Fisher LM, Lawrence JM, Josty IC, Hopewell R, Margerrison EE, Cullen ME.

Am J Med. 1989 Nov 30;87(5A):2S-8S.

PMID:
2574005
17.

Cloning and characterization of a DNA gyrase A gene from Escherichia coli that confers clinical resistance to 4-quinolones.

Cullen ME, Wyke AW, Kuroda R, Fisher LM.

Antimicrob Agents Chemother. 1989 Jun;33(6):886-94.

18.

DNA gyrase complex with DNA: determinants for site-specific DNA breakage.

Fisher LM, Barot HA, Cullen ME.

EMBO J. 1986 Jun;5(6):1411-8.

19.

DNA breakage by Escherichia coli DNA gyrase in vitro and in vivo.

Fisher LM, Barot HA, Cullen ME, Hulton CS.

Biochem Soc Trans. 1986 Apr;14(2):493-6. No abstract available.

PMID:
3011553

Supplemental Content

Loading ...
Support Center